Communiqués CONMED Corporation Deutsche Boerse AG

Actions

EC8

US2074101013

Equipement, fournitures et distribution médicale

Temps réel estimé Tradegate 16:35:08 18/08/2026			Varia. 5j.	Varia. 1 janv.
43,60 ^EUR	+3,32 %		+1,40 %	+24,57 %

30/07	CONMED : hausse du bénéfice ajusté et du chiffre d'affaires au T2 ; relèvement des prévisions pour 2024	MT
30/07	Transcript : CONMED Corporation, Q2 2026 Earnings Call, Jul 29, 2026

Communiqués

29/07	Conmed: Q2 Earnings Snapshot	AQ
29/07	CONMED Corporation Reports Second Quarter 2026 Financial Results; Updates Full Year 2026 Guidance	BU
23/07	CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula	AQ
22/07	CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal® Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula	BU
20/07	CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting	BU
02/07	CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026	BU
17/06	CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer	BU
20/05	CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors	BU
30/04	CONMED : Investor Presentation Q1 2026	PU
29/04	Conmed: Q1 Earnings Snapshot	AQ
29/04	CONMED Corporation Announces First Quarter 2026 Financial Results	BU
02/04	CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026	BU
28/01	Conmed: Q4 Earnings Snapshot	AQ
28/01	CONMED : Investor Presentation Q4 2025	PU
28/01	CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results	BU
12/01	CONMED : CNMD JPM Presentation 2026	PU
08/01	CONMED Corporation Announces Chief Financial Officer Transition	BU
05/01	CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference	BU
05/01	CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026	BU
05/12	CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines	BU
05/11	Conmed: Q3 Earnings Snapshot	AQ
05/11	CONMED : Investor Presentation Q3 2025	PU
05/11	CONMED Corporation Announces Third Quarter 2025 Financial Results	BU
02/10/25	CONMED Corporation to Announce Third Quarter 2025 Financial Results on November 5, 2025	BU
09/09/25	CONMED Corporation Adds Kim Kelderman to its Board of Directors	BU